The Exterior InteriorCan pseudo-natural environments, produced through video projections, improve dementia related symptoms and behaviours?

Not Applicable

• Conditions: Behavioural Disturbances; Depression; Circadian Rhythmicity / Sleep Disturbances; Dementia; Mental Health - Studies of normal psychology, cognitive function and behaviour; Neurological - Dementias; Mental Health - Depression

• Registration Number: ACTRN12615000212550
• Lead Sponsor: Associate Professor, Dr Dianne Smith

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

Individuals residing in an institutional care facility within the metropolitan area of Perth, Western Australia.

Individuals with a confirmed dementia diagnosis.

Individuals with active behavioural symptoms (assessed using the Cohen-Mansfield Agitation Inventory) with a frequency score of 4 (weekly) in at least two items of the CMAI or a total score greater than 45.

Exclusion Criteria

Individuals who are significantly visually impaired.

Individuals who have a medically diagnosed sleep breathing disorder (sleep apnoea).

Individuals who have a seizure disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in type and frequency of behaviours measured using the Cohen-Mansfield Agitation Inventory (Long Form) [CMAI][From baseline and every 3 weeks prior to intervention commencement (week 3, 6, 9 and 12), during intervention (week 15, 18, 21 and 24) and post intervention cessation (week 27, 30 and 33). Total of 11 measurement points.];Mean Pittsburgh Sleep Quality Index [PSQI] score[From baseline and every 12 weeks (week 0, 12, 24, 36). Total of 4 measurement points.];Mean Cornell Scale for Depression in Dementia [CSDD] score[From baseline and every 12 weeks (week 0, 12, 24, 36). Total of 4 measurement points.]

Secondary Outcome Measures

Name	Time	Method
Mean incidence of physical and pharmacological restrain use assessed through Clinical Notes.[Weekly from baseline (week 0) to (week 36). Total of 37 measurement points.];Mean incidence of falls assessed through Clinical Notes.[Weekly from baseline (week 0) to (week 36). Total of 37 measurement points.];Mean incidence of sundown syndrome behaviours assessed through Clinical Notes.[Weekly from baseline (week 0) to (week 36). Total of 37 measurement points.];Mean incidence of social interaction assessed through Clinical Notes.[Weekly from baseline (week 0) to (week 36). Total of 37 measurement points.]